These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34548190)

  • 1. Implications of reactive oxygen species on cancer formation and its treatment.
    Shah MA; Rogoff HA
    Semin Oncol; 2021 Jun; 48(3):238-245. PubMed ID: 34548190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies.
    Li J; Lim JYS; Eu JQ; Chan AKMH; Goh BC; Wang L; Wong AL
    Antioxid Redox Signal; 2024 Aug; 41(4-6):322-341. PubMed ID: 38445392
    [No Abstract]   [Full Text] [Related]  

  • 3. The Role of Reactive Oxygen Species in Tumor Treatment and its Impact on Bone Marrow Hematopoiesis.
    Chen Y; Luo X; Zou Z; Liang Y
    Curr Drug Targets; 2020; 21(5):477-498. PubMed ID: 31736443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of reactive oxygen species: an emerging approach for cancer therapy.
    Zou Z; Chang H; Li H; Wang S
    Apoptosis; 2017 Nov; 22(11):1321-1335. PubMed ID: 28936716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
    Fang J; Seki T; Maeda H
    Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of oxidative stress as an anticancer strategy.
    Gorrini C; Harris IS; Mak TW
    Nat Rev Drug Discov; 2013 Dec; 12(12):931-47. PubMed ID: 24287781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species in redox cancer therapy.
    Tong L; Chuang CC; Wu S; Zuo L
    Cancer Lett; 2015 Oct; 367(1):18-25. PubMed ID: 26187782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating ROS to overcome multidrug resistance in cancer.
    Cui Q; Wang JQ; Assaraf YG; Ren L; Gupta P; Wei L; Ashby CR; Yang DH; Chen ZS
    Drug Resist Updat; 2018 Nov; 41():1-25. PubMed ID: 30471641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy.
    Nogueira V; Hay N
    Clin Cancer Res; 2013 Aug; 19(16):4309-14. PubMed ID: 23719265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors.
    Smith DG; Magwere T; Burchill SA
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):229-49. PubMed ID: 21342042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting antioxidants for cancer therapy.
    Glasauer A; Chandel NS
    Biochem Pharmacol; 2014 Nov; 92(1):90-101. PubMed ID: 25078786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
    Kwon S; Ko H; You DG; Kataoka K; Park JH
    Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROS Modulator Molecules with Therapeutic Potential in Cancers Treatments.
    Nicco C; Batteux F
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29301225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
    Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
    Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Production of Reactive Oxygen Species as an Anticancer Strategy.
    Marioli-Sapsakou GK; Kourti M
    Anticancer Res; 2021 Dec; 41(12):5881-5902. PubMed ID: 34848443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of reactive oxygen species in cancers: recent advances.
    Ganesh JM; P P; Dharmarajan A; Warrier S; Gandhirajan RK
    Free Radic Res; 2022; 56(5-6):447-470. PubMed ID: 36214686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental therapeutics: targeting the redox Achilles heel of cancer.
    Cabello CM; Bair WB; Wondrak GT
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1022-37. PubMed ID: 18058573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive oxygen species in cancer: Current findings and future directions.
    Nakamura H; Takada K
    Cancer Sci; 2021 Oct; 112(10):3945-3952. PubMed ID: 34286881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive Oxygen Species (ROS): Key Components in Cancer Therapies.
    Sahoo BM; Banik BK; Borah P; Jain A
    Anticancer Agents Med Chem; 2022; 22(2):215-222. PubMed ID: 34102991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids.
    Khan AQ; Rashid K; AlAmodi AA; Agha MV; Akhtar S; Hakeem I; Raza SS; Uddin S
    Biomed Pharmacother; 2021 Nov; 143():112142. PubMed ID: 34536761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.